R
Robert G. Hart
Researcher at University of British Columbia
Publications - 1
Citations - 663
Robert G. Hart is an academic researcher from University of British Columbia. The author has contributed to research in topics: Warfarin & Aspirin. The author has an hindex of 1, co-authored 1 publications receiving 429 citations.
Papers
More filters
Journal ArticleDOI
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Robert G. Hart,Mukul Sharma,Hardi Mundl,Scott E. Kasner,Shrikant I. Bangdiwala,Scott D. Berkowitz,Balakumar Swaminathan,Pablo M. Lavados,Yongjun Wang,Yilong Wang,Antonio Dávalos,Nikolay Shamalov,Robert Mikulik,Luís Cunha,Arne Lindgren,Antonio Arauz,Wilfried Lang,Anna Członkowska,Jens Eckstein,Rubens José Gagliardi,Pierre Amarenco,Sebastian F. Ameriso,Turgut Tatlisumak,Roland Veltkamp,Graeme J. Hankey,Danilo Toni,Daniel Bereczki,Shinichiro Uchiyama,George Ntaios,Byung-Woo Yoon,Raf Brouns,Matthias Endres,K Muir,Natan M. Bornstein,Şerefnur Öztürk,Martin O'Donnell,Matthys M. De Vries Basson,Guillaume Paré,Calin Pater,Bodo Kirsch,Patrick Sheridan,Gary Peters,Jeffrey I. Weitz,W. Frank Peacock,Ashkan Shoamanesh,Oscar R. Benavente,Campbell D. Joyner,Ellison Themeles,Stuart J. Connolly +48 more
TL;DR: Rivaroxaban was not superior to aspirin with regard to the prevention of recurrent stroke after an initial embolic stroke of undetermined source and was associated with a higher risk of bleeding.